CLVLF
Price
$8.45
Change
+$0.07 (+0.84%)
Updated
Nov 26 closing price
SEPSF
Price
$0.06
Change
+$0.01 (+25.00%)
Updated
Dec 4 closing price
Ad is loading...

CLVLF vs SEPSF

Header iconCLVLF vs SEPSF Comparison
Open Charts CLVLF vs SEPSFBanner chart's image
Clinuvel Pharmaceuticals
Price$8.45
Change+$0.07 (+0.84%)
Volume$480
CapitalizationN/A
ASEP Medical Holdings
Price$0.06
Change+$0.01 (+25.00%)
Volume$35.9K
CapitalizationN/A
CLVLF vs SEPSF Comparison Chart
Loading...
View a ticker or compare two or three
VS
CLVLF vs. SEPSF commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLVLF is a Hold and SEPSF is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (CLVLF: $8.45 vs. SEPSF: $0.05)
Brand notoriety: CLVLF and SEPSF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLVLF: 41% vs. SEPSF: 207%
Market capitalization -- CLVLF: $390.38M vs. SEPSF: $2.7M
CLVLF [@Biotechnology] is valued at $390.38M. SEPSF’s [@Biotechnology] market capitalization is $2.7M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLVLF’s FA Score shows that 1 FA rating(s) are green whileSEPSF’s FA Score has 1 green FA rating(s).

  • CLVLF’s FA Score: 1 green, 4 red.
  • SEPSF’s FA Score: 1 green, 4 red.
According to our system of comparison, CLVLF is a better buy in the long-term than SEPSF.

Price Growth

CLVLF (@Biotechnology) experienced а 0.00% price change this week, while SEPSF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.91%, and the average quarterly price growth was -1.42%.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
CLVLF($390M) has a higher market cap than SEPSF($2.7M). CLVLF YTD gains are higher at: -19.677 vs. SEPSF (-68.867).
CLVLFSEPSFCLVLF / SEPSF
Capitalization390M2.7M14,450%
EBITDAN/AN/A-
Gain YTD-19.677-68.86729%
P/E Ratio18.99N/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
CLVLF: Fundamental Ratings
CLVLF
OUTLOOK RATING
1..100
47
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
39
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
81
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

CLVLF and

Correlation & Price change

A.I.dvisor tells us that CLVLF and IONS have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLVLF and IONS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLVLF
1D Price
Change %
CLVLF100%
N/A
IONS - CLVLF
28%
Poorly correlated
-1.10%
MCRB - CLVLF
24%
Poorly correlated
-1.09%
SEPSF - CLVLF
24%
Poorly correlated
N/A
PXXLF - CLVLF
23%
Poorly correlated
N/A
BITRF - CLVLF
22%
Poorly correlated
-8.18%
More

SEPSF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SEPSF has been loosely correlated with EYPT. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if SEPSF jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SEPSF
1D Price
Change %
SEPSF100%
N/A
EYPT - SEPSF
34%
Loosely correlated
+5.39%
ATHE - SEPSF
29%
Poorly correlated
-1.73%
CVM - SEPSF
25%
Poorly correlated
+16.45%
CLVLF - SEPSF
24%
Poorly correlated
N/A
SKYE - SEPSF
21%
Poorly correlated
-0.91%
More